Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Amonkar, Mayur M.
~ 100  Ergebnisse:
Personensuche X
?
1

Clinical outcomes for previously treated patients with adva..:

Amonkar, Mayur M ; Abderhalden, Lauren A ; Fox, Grace E...
Future Oncology.  20 (2024)  13 - p. 863-876 , 2024
Link: https://doi.org/10.2217/..
 
?
2

Clinical Outcomes for Previously Treated Patients with Adva..:

Abderhalden, Lauren A. ; Wu, Ping ; Amonkar, Mayur M....
Journal of Gastrointestinal Cancer.  54 (2023)  4 - p. 1031-1045 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Real-world treatment patterns and clinical outcomes for che..:

Amonkar, Mayur M. ; Chase, Monica ; Myer, Nicole M....
Cancer Treatment and Research Communications.  36 (2023)  - p. 100712 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Clinical outcomes of chemotherapy-based therapies for previ..:

Amonkar, Mayur M. ; Abderhalden, Lauren A. ; Frederickson, Andrew M....
International Journal of Colorectal Disease.  38 (2023)  1 - p. , 2023
Link: https://doi.org/10.1007/..
 
?
5

Health-related quality of life in patients treated with pem..:

Maio, Michele ; Amonkar, Mayur M. ; Norquist, Josephine M....
European Journal of Cancer.  169 (2022)  - p. 188-197 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Adjusting for treatment switching in the METRIC study shows..:

Latimer, Nicholas R. ; Bell, Helen ; Abrams, Keith R...
Cancer Medicine.  5 (2016)  5 - p. 806-815 , 2016
Link: https://doi.org/10.1002/..
 
?
7

Adjusting for the Confounding Effects of Treatment Switchin..:

Latimer, Nicholas R. ; Abrams, Keith R. ; Amonkar, Mayur M...
The Oncologist.  20 (2015)  7 - p. 798-805 , 2015
Link: https://doi.org/10.1634/..
 
?
8

Health-related quality of life impact in a randomised phase..:

Schadendorf, Dirk ; Amonkar, Mayur M. ; Stroyakovskiy, Daniil...
European Journal of Cancer.  51 (2015)  7 - p. 833-840 , 2015
Link: https://doi.org/10.1016/..
 
?
9

Cost Effectiveness of Dabrafenib as a First-Line Treatment ..:

Delea, Thomas E. ; Amdahl, Jordan ; Wang, Alice..
PharmacoEconomics.  33 (2014)  4 - p. 367-380 , 2014
Link: https://doi.org/10.1007/..
 
?
10

Cost-effectiveness of lapatinib plus capecitabine in women ..:

Delea, Thomas E. ; Tappenden, Paul ; Sofrygin, Oleg...
The European Journal of Health Economics.  13 (2012)  5 - p. 589-603 , 2012
Link: https://www.jstor.org/st..
 
?
11

Economic burden of resected squamous cell carcinoma of the ..:

Kim, Kun ; Amonkar, Mayur M ; Högberg, Daniel.
Head & Neck Oncology.  3 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
12

Cost-effectiveness of lapatinib plus capecitabine in women ..:

Delea, Thomas E. ; Tappenden, Paul ; Sofrygin, Oleg...
The European Journal of Health Economics.  13 (2011)  5 - p. 589-603 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Quality of Life in Hormone Receptor–Positive HER-2+ Metasta..:

Sherrill, Beth ; Amonkar, Mayur M. ; Sherif, Bintu...
The Oncologist.  15 (2010)  9 - p. 944-953 , 2010
Link: https://doi.org/10.1634/..
 
?
14

Lapatinib plus capecitabine versus capecitabine alone for H..:

Zhou, Xiaolei ; Cella, David ; Cameron, David...
Breast Cancer Research and Treatment.  117 (2009)  3 - p. 577-589 , 2009
Link: https://doi.org/10.1007/..
 
?
15

Descriptive analysis of concomitant prescription medication..:

Gold, Deborah T. ; Bonnick, Sydney Lou ; Amonkar, Mayur M....
Gender Medicine.  5 (2008)  4 - p. 374-384 , 2008
Link: https://doi.org/10.1016/..
 
1-15